Enduring Material

• The Colorado Medical Society designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
• The Colorado Medical Society designates this enduring material for a maximum of 1 Hour(s) Attendance w/ No Credit. Participants should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity enables the learner to earn credit toward the CME requirement(s) of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.

Course Overview

Nearly 1 in 10 adults and nearly 15% of children suffer the fluctuating symptom patterns of abdominal pain, disturbed defecation, and extra-intestinal symptoms associated with Irritable Bowel Syndrome. IBS-C and IBS-D represents a significant health burden owing to direct medical costs and indirect costs. Misdiagnosis and under treatment leads to waste and unnecessary patient suffering. Diet, stress, and other sociocultural factors can influence prevalence, health care–seeking behavior, symptoms, and treatment response. Regrettably, practicing physicians and mid-level providers do not always fully understand the pathways and treatment options available now and those in development.

Topics to be covered in this interactive seminar include:

An overview of Irritable Bowel Syndrome with Constipation and with Diarrhea
Epidemiology - Clinical Presentation and Treating Adults & Children
Pathogenesis of IBS-C and IBS-D
An updated classification system for IBS, the Rome IV diagnostic criteria
Exploring new studies on sucrase-isomaltase deficiency with IBS-D and Linoclotide for abdominal symptoms
Management of IBS Patients through Dietary approaches, Anti-spasmodic therapies, and Behavioral Approaches
Recently approved therapeutic agents for IBS-C and IBS-D
Patient care management for Advanced Discussion -practice clinicians and specialty nurse

CMS staff and planners of this activity have no relevant financial relationships with ACCME defined ineligible companies to disclose.

Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Anthony Lembo, MD has disclosed a financial relationship with one or more ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:

• Vibrant - Consulting - Relationship Has Not Ended
• Takeda - Consulting - Relationship Has Not Ended
• Atmo - Advisory Committee Member - Relationship Has Not Ended
• Ironwood - Advisory Committee Member - Relationship Has Not Ended
• Gemelli - Advisory Committee Member - Relationship Has Not Ended

0 %

50 %

2/11/2025